基于MRI栖息地影像组学预测高级别浆液性卵巢癌患者铂类耐药的多中心研究
本研究在3家医院的394例高级别浆液性卵巢癌患者中,基于T2WI、CE-T1WI和ADC图进行K-means聚类构建栖息地模型,并与常规影像组学模型和深度学习模型比较预测铂类化疗反应。栖息地模型AUC为0.710,高于影像组学模型的0.640和深度学习模型的0.603;结合栖息地特征与新辅助化疗的列线图AUC最高,为0.721,且NRI和IDI均为正值。
要点
- 栖息地2(弱强化、高ADC值、中等T2WI信号)在铂耐药与铂敏感组间差异有统计学意义(P < 0.05)。
- 栖息地模型AUC 0.710,高于影像组学模型0.640和深度学习模型0.603。
- 列线图结合栖息地特征与新辅助化疗,AUC 0.721为四模型最高,NRI和IDI均为正值。
核心结论
- 基于MRI的栖息地影像组学有潜力预测高级别浆液性卵巢癌患者的铂类化疗反应,结合栖息地特征与新辅助化疗的列线图性能最佳且模型增益良好。
研究设计与样本
- 回顾性研究,纳入3家医院的394例高级别浆液性卵巢癌患者,基于T2WI、CE-T1WI和ADC图进行K-means聚类,分别构建影像组学模型、栖息地模型和深度学习模型。
关键影像表现/征象
- 聚类得到3个栖息地,栖息地2表现为弱强化、高ADC值和中等T2WI信号,在铂耐药与铂敏感组间差异有统计学意义(P < 0.05)。
诊断标准与关键数值
- 栖息地模型预测铂耐药的AUC为0.710,高于影像组学模型的0.640和深度学习模型的0.603。
- 列线图结合栖息地特征与临床独立预测因子(新辅助化疗),AUC为0.721,为四个模型中最高,NRI和IDI均为正值。
临床应用与阅片要点
- 基于T2WI、CE-T1WI和ADC图的栖息地聚类分析可用于识别铂耐药与铂敏感患者,栖息地2的特征差异有统计学意义(P < 0.05)。
- 结合栖息地特征与新辅助化疗的列线图预测性能最佳(AUC 0.721),NRI和IDI均为正值。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: This study aims to explore the feasibility of MRI-based habitat radiomics for predicting response of platinum-based chemotherapy in patients with high-grade serous ovarian carcinoma (HGSOC), and compared to conventional radiomics and deep learning models.
MATERIALS AND METHODS: A retrospective study was conducted on HGSOC patients from three hospitals. K-means algorithm was used to perform clustering on T2-weighted images (T2WI), contrast-enhanced T1-weighted images (CE-T1WI), and apparent diffusion coefficient (ADC) maps. After feature extraction and selection, the radiomics model, habitat model, and deep learning model were constructed respectively to identify platinum-resistant and platinum-sensitive patients. A nomogram was developed by integrating the optimal model and clinical independent predictors. The model performance and benefit was assessed using the area under the receiver operating characteristic curve (AUC), net reclassification index (NRI), and integrated discrimination improvement (IDI).
RESULTS: A total of 394 eligible patients were incorporated. Three habitats were clustered, a significant difference in habitat 2 (weak enhancement, high ADC values, and moderate T2WI signal) was found between the platinum-resistant and platinum-sensitive groups (P < 0.05). Compared to the radiomics model (0.640) and deep learning model (0.603), the habitat model had a higher AUC (0.710). The nomogram, combining habitat signatures with a clinical independent predictor (neoadjuvant chemotherapy), yielded a highest AUC (0.721) among four models, with positive NRI and IDI.
CONCLUSION: MRI-based habitat radiomics had the potential to predict response of platinum-based chemotherapy in patients with HGSOC. The nomogram combining with habitat signature had a best performance and good model gains for identifying platinum-resistant patients.
引用
- Bi Q, Miao K, Xu N, et al. Habitat Radiomics Based on MRI for Predicting Platinum Resistance in Patients with High-Grade Serous Ovarian Carcinoma: A Multicenter Study. Acad Radiol. 2023. PMID: 38129227. doi:10.1016/j.acra.2023.11.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。